Publikationen von Christoph W. Turck
Alle Typen
Zeitschriftenartikel (177)
81.
Zeitschriftenartikel
264 (4), S. 311 - 316 (2014)
S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 82.
Zeitschriftenartikel
128 (6), S. 807 - 817 (2014)
Analysis of quantitative trait loci in mice suggests a role of Enoph1 in stress reactivity. JOURNAL OF NEUROCHEMISTRY 83.
Zeitschriftenartikel
13 (1 (Special Issue)), S. 147 - 157 (2014)
Deciphering the Human Brain Proteome: Characterization of the Anterior Temporal Lobe and Corpus Callosum As Part of the Chromosome 15-centric Humane Proteome Project Human Proteome Project. JOURNAL OF PROTEOME RESEARCH 84.
Zeitschriftenartikel
4, e352 (2014)
Plasma fibrinogen: now also an antidepressant response marker? TRANSLATIONAL PSYCHIATRY 85.
Zeitschriftenartikel
13 (23-24), S. 3548 - 3553 (2013)
The human oligodendrocyte proteome. PROTEOMICS 86.
Zeitschriftenartikel
47 (11), S. 1572 - 1580 (2013)
Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters. JOURNAL OF PSYCHIATRIC RESEARCH 87.
Zeitschriftenartikel
74 (6), S. E5 - E10 (2013)
Proteomic Similarities Between Heterozygous Reeler Mice and Schizophrenia [Correspondence]. BIOLOGICAL PSYCHIATRY 88.
Zeitschriftenartikel
88 (Special Issue: New Horizons and Applications for Proteomics [EuPA 2012]), S. 27 - 33 (2013)
N-15 metabolic labeling: Evidence for a stable isotope effect on plasma protein levels and peptide chromatographic retention times. JOURNAL OF PROTEOMICS 89.
Zeitschriftenartikel
5, 25 (2013)
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. GENOME MEDICINE 90.
Zeitschriftenartikel
27 (3), S. 491 - 510 (2013)
B-Raf and CRHR1 Internalization Mediate Biphasic ERK1/2 Activation by CRH in Hippocampal HT22 Cells. MOLECULAR ENDOCRINOLOGY 91.
Zeitschriftenartikel
46 (10), S. 1359 - 1365 (2012)
Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. Journal of Psychiatric Research 92.
Zeitschriftenartikel
6 (2), S. 189 - 192 (2012)
Proteomic biomarkers for psychiatric disorders: a progress update. Biomarkers in Medicine 93.
Zeitschriftenartikel
37 (4), S. 1013 - 1025 (2012)
Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology. Neuropsychopharmacology 94.
Zeitschriftenartikel
262 (2), S. 167 - 172 (2012)
Differential expression of HINT1 in schizophrenia brain tissue. European Archives of Psychiatry and Clinical Neuroscience 95.
Zeitschriftenartikel
7 (2), e30576 (2012)
Segmentation of Multi-Isotope Imaging Mass Spectrometry Data for Semi-Automatic Detection of Regions of Interest. PLoS ONE 96.
Zeitschriftenartikel
35 (3), S. 412 - 422 (2012)
Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. European Journal of Neuroscience 97.
Zeitschriftenartikel
75 (1), S. 4 - 17 (2011)
Facing challenges in Proteomics today and in the coming decade: Report of Roundtable Discussions at the 4th EuPA Scientific Meeting, Portugal, Estoril 2010. Journal of Proteomics 98.
Zeitschriftenartikel
70 (11), S. 1074 - 1082 (2011)
Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways. Biological Psychiatry 99.
Zeitschriftenartikel
1, e58 (2011)
Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation. Translational Psychiatry 100.
Zeitschriftenartikel
10 (12), doi: 10.1074/mcp.M111.008110 (2011)
Proteomic and Metabolomic Profiling of a Trait Anxiety Mouse Model Implicate Affected Pathways. Molecular & Cellular Proteomics